|
|
| Line 47: |
Line 47: |
|
| |
|
| ====Dosage forms not intended for injection==== | | ====Dosage forms not intended for injection==== |
| | | See [[List of psychoactive substances to avoid#Dosage forms]] |
| =====Tablets=====
| |
| '''It is extremely important to never inject pills''' as they contain pill binders that may congregate and cause blood clots and other serious bodily harm. This risk may be mitigated by the use of micron filters and extraction of the active pill ingredient, but it is not advised to inject pills of any kind. This issue is most often seen with pills that contain [[oxycodone]]. When crushed these pills may look safe to inject, but they may harbor pill binders and other materials that can clog up the veins and cause blockages in the bloodstream, resulting in circulation issues and kidney complications.<ref>{{Citation | title=What Are The Dangers of Snorting or Injecting OxyContin? | url=https://americanaddictioncenters.org/prescription-drugs/smoking-snorting-injecting}} </ref>
| |
| | |
| Talc from crushed tablets can cause:
| |
| * '''[https://en.wikipedia.org/wiki/Emphysema Emphysema]''' - Emphysema, or pulmonary emphysema, is a lower respiratory tract disease. The intravenous use of [[methylphenidate]], commonly marketed as Ritalin and widely used as a stimulant drug in the treatment of attention deficit hyperactivity disorder, can lead to emphysematous changes known as [https://en.wikipedia.org/wiki/Emphysema#Ritalin_lung Ritalin lung].
| |
| * '''[https://en.wikipedia.org/wiki/Pulmonary_talcosis Pulmonary talcosis]''' - Pulmonary talcosis is a pulmonary disorder caused by talc. The injection of talc from crushed pills has been associated with pulmonary talcosis in intravenous drug users.<ref name="pmid6655726">{{Cite journal|last1=Davis|first1=LL.|date=Dec 1983|title=Pulmonary "mainline" granulomatosis: talcosis secondary to intravenous heroin abuse with characteristic x-ray findings of asbestosis.|journal=J Natl Med Assoc|volume=75|issue=12|pages=1225–8|pmc=2561715|pmid=6655726}}</ref>
| |
| | |
| =====Transdermal patches=====
| |
| Main: [[Dosage form#Uneven distributed substances in drug reservoirs]]
| |
| | |
| Fentany patches are designed for trandermal use, not intravenous injection. Thus, fentanyl solutions applied to transdermal patches during the manufacturing process does not warrant homogenous distribution. For example, a top corner may contain little fentanyl, while the center of the patch may contain significantly higher concentrate.
| |
| | |
| =====Vape liquids=====
| |
| Case Report: Fatal Intravenous Injection of Electronic Nicotine Delivery System Refilling Solution.<ref>{{cite journal |last1=Thornton |first1=SL |last2=Oller |first2=L |last3=Sawyer |first3=T |title=Fatal intravenous injection of electronic nicotine delivery system refilling solution. |journal=Journal of medical toxicology : official journal of the American College of Medical Toxicology |date=June 2014 |volume=10 |issue=2 |pages=202-4 |doi=10.1007/s13181-014-0380-9 |pmid=24500565 |pmc=4057540}}</ref>
| |
|
| |
|
| ===Virus survival time outside the body=== | | ===Virus survival time outside the body=== |
